Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol

Fig. 1

The average biological effective dose calculated using the formula BED = Total dose * (1 + (Fraction dose /α/β)), α/β ratio = 10. Silico study of 16 newly diagnosed glioblastoma patients resulted a higher BED compared with the conventional radiotherapy regimen. BED: biological effective dose; IMRT: Intensity-modulated radiation therapy; HSRT: Hypofractionated stereotactic radiotherapy

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us